Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition and application thereof to preparation of medicament for treating cerebrovascular disease

A technology for cerebrovascular disease and a composition, which is applied in the application field of preparing medicines for treating cerebrovascular disease, can solve the problems of unknown degree, low purity, abnormal liver function, etc., so as to reduce the effective dose, increase the therapeutic effect and toxicity. small effect

Inactive Publication Date: 2012-06-06
JIANGSU SIMCERE PHARMACEUTICAL R & D CO LTD
View PDF0 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

3-Methyl-1-phenyl-2-pyrazolin-5-one clinical dosage for adults is 60mg / d (mg / day), studies have found that it has certain side effects, such as acute renal failure of unknown degree, hepatic Adverse reactions such as dysfunction, thrombocytopenia and disseminated intravascular coagulation
According to the 2010 edition of the Chinese Pharmacopoeia, natural borneol contains no less than 96.0% borneol, synthetic borneol contains no less than 55.0%, and about 38% isoborneol. Its purity is not high and it is not the main component. Especially the presence of camphor may have some unwanted effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition and application thereof to preparation of medicament for treating cerebrovascular disease
  • Pharmaceutical composition and application thereof to preparation of medicament for treating cerebrovascular disease
  • Pharmaceutical composition and application thereof to preparation of medicament for treating cerebrovascular disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] Get Edaravone 2g (gram), add in the propylene glycol solution of 200g, stir and make it dissolve completely, slowly add water for injection and make it dissolve and reach 1000ml (milliliter), to obtain final product.

Embodiment 2

[0020] Take 2 g of (+)-2-camphor, add it to 200 g of propylene glycol solution, stir to dissolve completely, slowly add water for injection to dissolve to 1000 ml, and obtain.

Embodiment 3

[0022] Take 1 g of (+)-2-camphor, add it to 200 g of propylene glycol solution, stir to dissolve it completely, slowly add water for injection to dissolve it to 1000 ml, and obtain.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
purityaaaaaaaaaa
Login to View More

Abstract

A pharmaceutical composition comprises 3-methyl-1-phenyl-2-pyrazoline-5-ketone and (+)-2-borneol. The pharmaceutical composition can be used in treating cerebrovascular disease and has lower toxic and side effects.

Description

technical field [0001] The invention relates to a pharmaceutical composition and its application in the preparation of medicines for treating cerebrovascular diseases. Background technique [0002] Cerebrovascular disease is a group of diseases that seriously endanger human health, and has become one of the important causes of human disability and death. [0003] Cerebrovascular disease (CVD for short) refers to brain lesions caused by abnormalities in cerebrovascular vessels. Stroke generally refers to acute cerebrovascular disease. [0004] Cerebrovascular diseases can be simply divided into two categories, one is ischemic cerebrovascular disease caused by the reduction or interruption of blood flow, and the other is hemorrhagic cerebrovascular disease caused by rupture of blood vessels. Ischemic cerebrovascular disease is mainly cerebral infarction (including cerebral thrombosis and cerebral embolism). In addition to cerebral infarction, there is another type of ischemi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4152A61K31/045A61P9/10
Inventor 杨士豹华垚
Owner JIANGSU SIMCERE PHARMACEUTICAL R & D CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com